🔗 Permalink

Assignee profile:

Sequoia Pharmaceuticals, Inc.

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

Last publication date:

2012-06-07

Patent Grants:

Last grant date:

2014-04-22

Top Inventors for applications by Sequoia Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Sequoia Pharmaceuticals, Inc.:

Michael EISSENSTAT 16 Frederick, MD United States
Dehui Duan 5 Frederick, MD United States
John W. Erickson 4 Potomac, MD United States
Abelardo Silva 3 Columbia, MD United States

Dehui DUAN 3 Gaithersburg, MD United States
John W. Erickson 3 Frederick, MD United States
Sergei GULNIK 3 Frederick, MD United States
Abelardo Silva 2 Ellicott City, MD United States

Jihye Kang 1 Gaithersburg, MD United States
Rongjuan Lu 1 Gaithersburg, MD United States
Greg Delahanty 1 Silver Spring, MD United States
Tatiana Guerassina 1 Frederick, MD United States

Greg Delahanty 1 Nottingham, MD United States
Gnana Ravi Rajendran 1 Gaithersburg, MD United States
Andrey Topin 1 Highland, MD United States
Sergi Gulnik 1 Frederick, MD United States

Ji-Hye KANG 1 Gaithersburg, MD United States
Pavel MAJER 1 Sykesville, MD United States
Ji-Hye Kang 1 Frederick, MD United States
Rongjian Lu 1 Gaithersburg, MD United States

Sang Uk Kang 1 Gaithersburg, MD United States

Recent patent applications by Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals, Inc. based in Gaithersburg, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-06-07 ✅ Patent 8,703,700 granted on 2014-04-22

US20120141414A1

Human necessities

Bimacrocylic HCV NS3 protease inhibitors

#2 | 2012-03-01 ✅ Patent 8,481,520 granted on 2013-07-09

US20120053132A1

Human necessities

Compositions and methods for inhibiting cytochrome P450

#3 | 2011-11-17 ✅ Patent 8,389,571 granted on 2013-03-05

US20110281824A1

Chemistry; metallurgy

Benzofuran derived HIV protease inhibitors

#4 | 2011-07-28 ✅ Patent 8,765,667 granted on 2014-07-01

US20110182854A1

Chemistry; metallurgy

HCV protease inhibitors

#5 | 2011-05-26 ✅ Patent 9,403,789 granted on 2016-08-02

US20110124578A1

Chemistry; metallurgy

Benzofuran-containing amino acid inhibitors of cytochrome P450

#6 | 2011-05-12 ✅ Patent 8,673,970 granted on 2014-03-18

US20110112137A1

Human necessities

HIV protease inhibitor and cytochrome p450 inhibitor combinations

#7 | 2011-04-28 ✅ Patent 8,952,056 granted on 2015-02-10

US20110098237A1

Chemistry; metallurgy

Methods for inhibiting drug degradation

#8 | 2011-04-28 ✅ Patent 8,906,647 granted on 2014-12-09

US20110098236A1

Chemistry; metallurgy

Diamide inhibitors of cytochrome P450

#9 | 2009-06-04 ✅ Patent 8,569,364 granted on 2013-10-29

US20090143408A1

Chemistry; metallurgy

5-substituted benzofurans as inhibitors of cytochrome P450 2D6

#10 | 2008-09-18 ✅ Patent 7,981,929 granted on 2011-07-19

US20080227744A1

Chemistry; metallurgy

Benzofuran derived HIV protease inhibitors

#11 | 2008-05-15 ✅ Patent 8,048,871 granted on 2011-11-01

US20080113945A1

Human necessities

Compositions and methods for inhibiting cytochrome P450

#12 | 2007-08-09

US20070185027A1

Chemistry; metallurgy

ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRUSES

#13 | 2006-12-28

US20060293286A1

Chemistry; metallurgy

Resistant-repellent retroviral protease inhibitors

#14 | 2006-11-16

US20060258737A1

Chemistry; metallurgy

Resistance-repellent retroviral protease inhibitors

#15 | 2006-11-16 ✅ Patent 7,151,163 granted on 2006-12-19

US20060258577A1

Chemistry; metallurgy

Antiviral agents for the treatment, control and prevention of infections by coronaviruses

#16 | 2006-09-19 ✅ Patent 7,109,230 granted on 2006-09-19

US10337349

Resistance-repellent retroviral protease inhibitors

#17 | 2005-12-01 ✅ Patent 7,378,441 granted on 2008-05-27

US20050267074A1

Chemistry; metallurgy

Resistance-repellent retroviral protease inhibitors

#18 | 2005-09-22 ✅ Patent 7,807,845 granted on 2010-10-05

US20050209301A1

Chemistry; metallurgy

Resistance-repellent retroviral protease inhibitors

Also check out Sequoia Pharmaceuticals, Inc.'s (Gaithersburg, United States) applicant profile with 2 patent applications submitted.

AssigneeID:

177563 ⎘